The ubiquitination of CKIP-1 mediated by Src aggravates diabetic renal fibrosis (original article)

Biochem Pharmacol. 2022 Dec:206:115339. doi: 10.1016/j.bcp.2022.115339. Epub 2022 Nov 5.

Abstract

Renal chronic inflammation is an important hallmark of diabetic renal fibrosis. Casein kinase 2 interacting protein 1 (CKIP-1) performs a nephroprotective role in the pathogenesis of diabetic nephropathy (DN), which is dramatically decreased in diabetic kidneys. However, whether CKIP-1 regulates inflammation to ameliorate renal fibrosis remains unclear and it is interesting to clarify the degradation mechanism of CKIP-1. Here, we identified CKIP-1 expression was down-regulated in diabetic kidneys and knockout (KO) of CKIP-1 increased c-Jun expression and extra cellular matrix (ECM) in kidneys of normal mice, and knockout (KO) of CKIP-1 further exacerbated renal inflammatory fibrosis in diabetic mice. Moreover, the activated Src kinase interacted with CKIP-1 at Lys252 and increased K48 linked polyubiquitination and proteasome degradation of CKIP-1 in HG induced GMCs and diabetic kidneys. Mechanistically, Src facilitating the binding of c-Cbl with CKIP-1 by promoting the phosphorylation of c-Cbl, thereby increasing Cbl-mediated ubiquitination of CKIP-1 to down-regulate CKIP-1 protein expression. Thus, our study highlighted the anti-inflammation role of CKIP-1 and clarified the mechanism of CKIP-1 degradation in DN.

Keywords: CKIP-1; Diabetic nephropathy; Phosphorylation; Src kinase; Ubiquitination; c-Cbl.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carrier Proteins / metabolism
  • Diabetes Mellitus, Experimental*
  • Diabetic Nephropathies* / metabolism
  • Fibrosis
  • Inflammation
  • Mice
  • Signal Transduction
  • Ubiquitination

Substances

  • Carrier Proteins
  • CKIP-1 protein, mouse